PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Ze-Yang Zeng

China Medical University

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines1

Latest

Everything in the corpus, newest first.

AUG 17, 2026 · JOURNAL ARTICLE

Factors influencing the efficacy of programmed cell death protein 1 / programmed death-ligand 1 inhibitors in non-small cell lung cancer

Journal of Clinical Question

A narrative review synthesizing evidence on factors influencing PD-1/PD-L1 inhibitor efficacy in NSCLC, prioritizing pivotal trials and consensus statements, to inform clinical decision-making and biomarker selection.

Expert GuidanceShuling Zhang Lung Cancer Research Studies Lung Cancer Treatments and Mutations

Reported

Objective response rate (ICI mono…approximately 20%

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support